• 1. Genus Spatholobus: a comprehensive review on ethnopharmacology, phytochemistry, pharmacology, and toxicology
  Yunlu Liu,Qian Xiang,Qi Liang,Jianyou Shi,Jun He Food Funct. 2022 13 7448

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Stigmastanes and derivatives

Hydroxysitosterol (CAS No. 34427-61-7): A Comprehensive Overview

Hydroxysitosterol, identified by the chemical compound code CAS No. 34427-61-7, is a naturally occurring phytosterol that has garnered significant attention in the field of pharmaceuticals and nutraceuticals due to its diverse biological activities. Phytosterols are plant-derived sterols that structurally resemble cholesterol but exhibit distinct physiological effects. Among these, Hydroxysitosterol stands out for its potential therapeutic applications, particularly in managing cardiovascular diseases, inflammatory conditions, and metabolic disorders.

The molecular structure of Hydroxysitosterol consists of a steroidal backbone with a hydroxyl group at the 3-position, which contributes to its unique chemical properties and biological interactions. This compound is primarily found in vegetable oils, seeds, and nuts, though it can also be synthesized chemically for research and industrial purposes. The widespread presence of Hydroxysitosterol in natural sources makes it an attractive candidate for dietary supplements and functional foods.

Recent studies have highlighted the anti-inflammatory and cholesterol-lowering properties of Hydroxysitosterol. Research published in peer-reviewed journals has demonstrated that this compound can inhibit the absorption of dietary cholesterol in the gut, thereby reducing serum cholesterol levels. This mechanism is particularly relevant in the context of hypercholesterolemia, a major risk factor for cardiovascular diseases. Moreover, Hydroxysitosterol has been shown to modulate immune responses by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6.

In clinical trials, Hydroxysitosterol has been evaluated for its efficacy in managing hyperlipidemia and preventing atherosclerosis. One notable study published in the *Journal of Lipid Research* reported that patients treated with Hydroxysitosterol experienced a significant reduction in LDL cholesterol levels compared to placebo groups. These findings support the potential use of Hydroxysitosterol as an adjunct therapy in lipid-lowering regimens. Additionally, research suggests that Hydroxysitosterol may have protective effects against oxidative stress, further contributing to its cardiovascular benefits.

The pharmacokinetics of Hydroxysitosterol have been extensively studied to understand its absorption, distribution, metabolism, and excretion (ADME) profiles. Studies indicate that Hydroxysitosterol is poorly absorbed from the gastrointestinal tract but can be bioactivated through enzymatic pathways in the liver. This limited absorption necessitates higher doses or frequent administration to achieve therapeutic effects. However, recent advancements in drug delivery systems have improved the bioavailability of Hydroxysitosterol, making it more viable for clinical applications.

Beyond its cardiovascular benefits, Hydroxysitosterol has shown promise in other therapeutic areas. Research has explored its potential role in alleviating symptoms associated with inflammatory bowel disease (IBD). Animal models have demonstrated that Hydroxysitosterol can reduce intestinal inflammation and improve gut barrier function. These findings are particularly encouraging given the rising prevalence of IBD globally. Furthermore, preliminary studies suggest that Hydroxysitosterol may have anticancer properties by inducing apoptosis in certain cancer cell lines.

The nutraceutical industry has embraced Hydroxysitosterol as a key ingredient due to its health-promoting properties. It is commonly added to functional foods such as margarines, yogurts, and spreads to enhance their cholesterol-lowering benefits. Regulatory agencies in various countries have recognized the safety and efficacy of Hydroxysitosterol, allowing its use as a food additive without strict limitations on dosage or application.

Future research directions for Hydroxysitosterol include exploring its mechanisms of action at the molecular level and identifying new therapeutic applications. Advances in metabolomics and proteomics are expected to provide deeper insights into how Hydroxysitosterol interacts with biological systems. Additionally, clinical trials with larger sample sizes are needed to confirm its efficacy and safety profile across diverse populations.

In conclusion, Hydroxysitosterol (CAS No. 34427-61-7) is a multifaceted compound with significant potential in preventive medicine and therapeutic interventions. Its ability to modulate lipid metabolism, reduce inflammation, and protect against oxidative stress makes it a valuable candidate for addressing chronic diseases such as cardiovascular disorders and IBD. As research continues to uncover new applications for this natural phytosterol, Hydroxysitosterol is poised to play an increasingly important role in human health management.

• 15780-16-2((3α,20S)-Dihydroxy Progesterone)
• 127776-77-6(fern-9(11)-ene-3beta,12beta-diol)
• 53527-35-8((3beta, 12alpha)-9(11)-Fernene-3, 12-diol)
• 75686-38-3((3beta,7beta)-Cholest-5-ene-3,7-diol,)
• 75686-39-4((3beta,7beta)-Cholest-5-ene-3,7-diol,)
• 99081-79-5((3beta,7alpha)-Ergosta-5,24(28)-diene-3,7-diol)
• 16840-37-2((3beta)-cholest-5-ene-3,7-diol)
• 139765-39-2((3beta, 7beta, 22E)-Cholesta-5, 22-diene-3, 7, 19-triol)
• 99081-81-9((3beta,7alpha)-Ergosta-5,24(28)-diene-3,7-diol)
• 135383-76-5(tirucalla-7,24-diene-3beta,21,23-triol)